Company Filing History:
Years Active: 2025
Title: Charlotte Revill: Innovator in Anticoagulant Research
Introduction
Charlotte Revill is a prominent inventor based in Leeds, GB. She has made significant contributions to the field of anticoagulant research, particularly through her innovative work on Factor XIIA inhibitors. Her research focuses on developing compounds that can effectively modulate Factor XII, which plays a crucial role in the blood coagulation process.
Latest Patents
Charlotte Revill holds 1 patent related to her groundbreaking work. The patent pertains to Factor XIIA inhibitors, which are compounds designed to inhibit Factor XIIa. This invention not only outlines the compounds of formula (I) but also details methods of treatment using these compounds. The compounds are particularly valuable as potential anticoagulants, offering new avenues for therapeutic intervention in coagulation disorders.
Career Highlights
Charlotte is affiliated with the University of Leeds, where she conducts her research and contributes to the academic community. Her work has garnered attention for its potential impact on medical treatments related to blood coagulation.
Collaborations
Charlotte collaborates with esteemed colleagues, including Helen Philippou and Richard James Foster. These partnerships enhance her research efforts and contribute to the advancement of knowledge in her field.
Conclusion
Charlotte Revill is a dedicated inventor whose work on Factor XIIA inhibitors represents a significant advancement in anticoagulant research. Her contributions are poised to influence future therapeutic strategies in managing coagulation disorders.